動脈炎性視網膜中央動脈阻塞1例_Chinese Journal of Ocular Fundus Diseases

Authors：

于召虎 ¹ , 殷釧杰 ² , 鄭加慶 ² , 石鑫 ³ , 于魯薇 ³ , 孫瑜 ² , 張珊珊 ² ,  婁華東 ² , 賀西亮 ¹

1. ;
2. ;
3. ;

Corresponding?author：

婁華東, Email: qdbylhd@163.com

Keywords：

巨細胞動脈炎; 視網膜中央動脈阻塞; 病例報告

DOI：

10.3760/cma.j.cn511434-20250513-00214

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 于召虎, 殷釧杰, 鄭加慶, 石鑫, 于魯薇, 孫瑜, 張珊珊, 婁華東, 賀西亮. 動脈炎性視網膜中央動脈阻塞1例. Chinese Journal of Ocular Fundus Diseases, 2026, 42(7): 610-612. doi: 10.3760/cma.j.cn511434-20250513-00214 Copy

1.	Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11. DOI: 10.1002/art.37715.
2.	Chacko JG, Chacko JA, Salter MW. Review of giant cell arteritis[J]. Saudi J Ophthalmol, 2015, 29(1): 48-52. DOI: 10.1016/j.sjopt.2014.10.001.
3.	Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis[J]. Arthritis Rheum, 1990, 33(8): 1122-1128. DOI: 10.1002/art.1780330810.
4.	Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis[J]. Am J Ophthalmol, 1998, 125(4): 509-520. DOI: 10.1016/s0002-9394(99)80192-5.
5.	Dumont A, Lecannuet A, Boutemy J, et al. Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: a case-control study[J]. Semin Arthritis Rheum, 2020, 50(2): 335-341. DOI: 10.1016/j.semarthrit.2019.09.008.
6.	Vodopivec I, Rizzo JF 3rd. Ophthalmic manifestations of giant cell arteritis[J]. Rheumatology (Oxford), 2018, 57(S2): S63-72. DOI: 10.1093/rheumatology/kex428.
7.	陳倩, 陳偉民, 馮超逸, 等. 眼部受累的巨細胞動脈炎臨床及影像特征分析[J]. 中國眼耳鼻喉科雜志, 2022, 22(1): 20-24, 30. DOI: 10.14166/j.issn.1671-2420.2022.01.005.Chen Q, Chen WM, Feng CY, et al. Clinical characteristics and imaging features of giant cell arteritis with ocular involvement[J]. Chin J Ophthalmol and Otorhinolaryngol, 2022, 22(1): 20-24, 30. DOI: 10.14166/j.issn.1671-2420.2022.01.005.
8.	Kovach JL, Bailey ST, Kim SJ, et al. Retinal and ophthalmic artery occlusions preferred practice pattern?[J]. Ophthalmology, 2025, 132(4): 270-302. DOI: 10.1016/j.ophtha.2024.12.024.
9.	Soriano A, Muratore F, Pipitone N, et al. Visual loss and other cranial ischaemic complications in giant cell arteritis[J]. Nat Rev Rheumatol, 2017, 13(8): 476-484. DOI: 10.1038/nrrheum.2017.98.
10.	中國研究型醫院學會神經眼科專業委員會, 陜西省研究型醫院學會神經眼科專業委員會, 魏世輝, 等. 中國視網膜中央動脈阻塞臨床診療專家共識[J]. 中國卒中雜志, 2024, 19(11): 1246-1267. DOI: 10.3969/j.issn.1673-5765.2024.11.002.Neuro-ophthalmology Professional Committee of the Chinese Society of Research Hospitals, Neuro-ophthalmology Professional Committee of the Shaanxi Society of Research Hospitals, Wei SH, et al. Expert consensus on clinical diagnosis and treatment of central retinal artery occlusion in China[J]. Chin J Stroke, 2024, 19(11): 1246-1267. DOI: 10.3969/j.issn.1673-5765.2024.11.002.
11.	Chen JJ, Leavitt JA, Fang C, et al. Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis[J]. Ophthalmology, 2016, 123(9): 1999-2003. DOI: 10.1016/j.ophtha.2016.05.008.
12.	Samson M, Greigert H, Ghesquière T, et al. Treatment of giant cell arteritis[J]. Presse Med, 2019, 48(9): 968-979. DOI: 10.1016/j.lpm.2019.06.002.

1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11. DOI: 10.1002/art.37715.
2. Chacko JG, Chacko JA, Salter MW. Review of giant cell arteritis[J]. Saudi J Ophthalmol, 2015, 29(1): 48-52. DOI: 10.1016/j.sjopt.2014.10.001.
3. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis[J]. Arthritis Rheum, 1990, 33(8): 1122-1128. DOI: 10.1002/art.1780330810.
4. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis[J]. Am J Ophthalmol, 1998, 125(4): 509-520. DOI: 10.1016/s0002-9394(99)80192-5.
5. Dumont A, Lecannuet A, Boutemy J, et al. Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: a case-control study[J]. Semin Arthritis Rheum, 2020, 50(2): 335-341. DOI: 10.1016/j.semarthrit.2019.09.008.
6. Vodopivec I, Rizzo JF 3rd. Ophthalmic manifestations of giant cell arteritis[J]. Rheumatology (Oxford), 2018, 57(S2): S63-72. DOI: 10.1093/rheumatology/kex428.
7. 陳倩, 陳偉民, 馮超逸, 等. 眼部受累的巨細胞動脈炎臨床及影像特征分析[J]. 中國眼耳鼻喉科雜志, 2022, 22(1): 20-24, 30. DOI: 10.14166/j.issn.1671-2420.2022.01.005.Chen Q, Chen WM, Feng CY, et al. Clinical characteristics and imaging features of giant cell arteritis with ocular involvement[J]. Chin J Ophthalmol and Otorhinolaryngol, 2022, 22(1): 20-24, 30. DOI: 10.14166/j.issn.1671-2420.2022.01.005.
8. Kovach JL, Bailey ST, Kim SJ, et al. Retinal and ophthalmic artery occlusions preferred practice pattern?[J]. Ophthalmology, 2025, 132(4): 270-302. DOI: 10.1016/j.ophtha.2024.12.024.
9. Soriano A, Muratore F, Pipitone N, et al. Visual loss and other cranial ischaemic complications in giant cell arteritis[J]. Nat Rev Rheumatol, 2017, 13(8): 476-484. DOI: 10.1038/nrrheum.2017.98.
10. 中國研究型醫院學會神經眼科專業委員會, 陜西省研究型醫院學會神經眼科專業委員會, 魏世輝, 等. 中國視網膜中央動脈阻塞臨床診療專家共識[J]. 中國卒中雜志, 2024, 19(11): 1246-1267. DOI: 10.3969/j.issn.1673-5765.2024.11.002.Neuro-ophthalmology Professional Committee of the Chinese Society of Research Hospitals, Neuro-ophthalmology Professional Committee of the Shaanxi Society of Research Hospitals, Wei SH, et al. Expert consensus on clinical diagnosis and treatment of central retinal artery occlusion in China[J]. Chin J Stroke, 2024, 19(11): 1246-1267. DOI: 10.3969/j.issn.1673-5765.2024.11.002.
11. Chen JJ, Leavitt JA, Fang C, et al. Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis[J]. Ophthalmology, 2016, 123(9): 1999-2003. DOI: 10.1016/j.ophtha.2016.05.008.
12. Samson M, Greigert H, Ghesquière T, et al. Treatment of giant cell arteritis[J]. Presse Med, 2019, 48(9): 968-979. DOI: 10.1016/j.lpm.2019.06.002.

Previous Article
RB1基因突變致良性視網膜細胞瘤1例
Next Article
孤立性視網膜星形細胞錯構瘤

Chinese Journal of Ocular Fundus Diseases

動脈炎性視網膜中央動脈阻塞1例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content